GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme.

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for ...

The regulatory agency will review MSD’s new drug application (NDA) for Welireg under a Priority Review, with a Prescription ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Tevogen Bio has expanded its partnership with Microsoft, aiming to further their collaboration centred on AI and advance ...

The UK biotech sector raised £3.5bn in 2024, the highest annual total since 2021 when £4.5bn was raised. The UK biotech ...

The FDA has approved the sBLA of Eisai and Biogen's LEQEMBI for maintenance dosing indicated for the early stages of ...

The financial challenges facing clinical trials have created a more risk-averse landscape. Yet digital solutions could be the key for sponsors and CROs to optimize budgets and resources. We explore ...